EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-Metaanalyse

Regenerative therapies for erectile dysfunction: a systematic review, Bayesian network meta-analysis, and meta-regression

David E Hinojosa-Gonzalez, Gal Saffati iD, Daniela Orozco Rendon iD, Troy La, Shane Kronstedt iD, Akhil Muthigi, Mohit Khera

The Journal of Sexual Medicine · 01.12.2024 · 21 (12) · 1152-1158

DOI: 10.1093/jsxmed/qdae131 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Journal of Sexual Medicine, online erschienen am 17.10.2024. Verfasst von David E Hinojosa-Gonzalez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Scott Department of Urology, Baylor College of Medicine, Houston, TX, 77030, United States. Hauptthemen laut MEDLINE: Erectile Dysfunction, Platelet-Rich Plasma, Stem Cell Transplantation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current guidelines advocate a shared decision-making process approach to erectile dysfunction management, and while there is growing interest in regenerative therapies such as stem cell therapy, platelet-rich plasma injections, and low-intensity shockwave therapy for erectile dysfunction, comparative data on the efficacy of these modalities are limited.

Aim

This systematic review and network meta-analysis aims to compare stem cell therapy, platelet-rich plasma injections, and low-intensity shockwave therapy for managing erectile dysfunction and quantify their impact on the International Index of Erectile Function (IIEF).

Methods

In January 2024, a systematic search of online databases was performed to identify randomized clinical trials related to stem cell therapy, platelet-rich plasma injections, and low-intensity shockwave therapy in erectile dysfunction. Eligible articles reported outcomes using the IIEF score. Data were inputted into Review Manager 5.4 for pairwise meta-analysis. Data were then used to build a network in R Studio. These networks were used to model 200 000 Markov Chains via MonteCarlo sampling. The results are expressed as standardized mean difference (SMD) with 95% credible intervals (CrI). Meta-regression was used to adjust for PDE5is use. Outcomes Impact on the International Index of Erectile Function.

Results

A total of 16 studies involving 907 patients were analyzed. The standardized mean difference (SMD) vs control for stem cell therapy was 0.92 [95% CrI –0.49, 2.3]. For platelet-rich plasma, the SMD vs control was 0.83 [95% CrI 0.15, 1.5], and for low-intensity shockwave therapy, the SMD vs control was 0.84 [95% CrI 0.49, 1.2]. When stratifying low-intensity shockwave therapy by dose, the SMD vs control at 0.15 mJ/mm2 was 1.1 [95% CrI 0.36, 1.9], while at 0.09 mJ/mm2, it was 0.75 [95% CrI 0.26, 1.2]. Meta-regression adjusting for the administration of PDE5 inhibitors yielded non-significant results. Clinical implications The findings suggest that stem cells, platelet-rich plasma, and low intensity shockwave therapy, particularly at 0.15 and 0.09 mJ/mm2, may offer improvements in erectile function. Strengths and limitations The strength is the robust statistical methods. Limitations are in heterogeneity in control groups and follow-up durations among included studies.

Conclusion

Shockwave therapy and platelet-rich plasma demonstrated statistically significant improvements, though the clinical relevance and extent of their impact remain questionable. Further research is necessary to determine the efficacy of stem cell therapies for erectile function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erectile DysfunctionPlatelet-Rich PlasmaStem Cell TransplantationHumansMaleBayes TheoremExtracorporeal Shockwave TherapyRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

erectile dysfunctionplatelet rich plasmaregenerative therapiesshockwavestem cells

Autor:innen und Institutionen

  • Scott Department of Urology, Baylor College of Medicine, Houston, TX, 77030, United States.
  • Department of Urology, Houston Methodist, Houston, TX, 77030, United States.

ORCID-Profile: Gal Saffati, Daniela Orozco Rendon, Shane Kronstedt

Zitieren

APA

Hinojosa-Gonzalez, D. E., Saffati, G., Orozco Rendon, D., La, T., Kronstedt, S., Muthigi, A., & Khera, M. (2024). Regenerative therapies for erectile dysfunction: a systematic review, Bayesian network meta-analysis, and meta-regression. The Journal of Sexual Medicine, 21(12), 1152-1158. https://doi.org/10.1093/jsxmed/qdae131

Vancouver

Hinojosa-Gonzalez DE, Saffati G, Orozco Rendon D, La T, Kronstedt S, Muthigi A, et al. Regenerative therapies for erectile dysfunction: a systematic review, Bayesian network meta-analysis, and meta-regression. The Journal of Sexual Medicine. 2024;21(12):1152-1158. doi:10.1093/jsxmed/qdae131

BibTeX
@article{HinojosaGonzalez2024,
  author = {Hinojosa-Gonzalez, David E and Saffati, Gal and Orozco Rendon, Daniela and La, Troy and Kronstedt, Shane and Muthigi, Akhil and Khera, Mohit},
  title = {Regenerative therapies for erectile dysfunction: a systematic review, Bayesian network meta-analysis, and meta-regression},
  journal = {The Journal of Sexual Medicine},
  year = {2024},
  volume = {21},
  number = {12},
  pages = {1152--1158},
  doi = {10.1093/jsxmed/qdae131}
}
Kostenlos starten →